Fampridin (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Fampridin" in German language version.

refsWebsite
Global rank German rank
4th place
7th place
68th place
29th place
813th place
69th place
924th place
87th place
low place
2,942nd place
low place
6,424th place
9,919th place
6,454th place
1st place
1st place
2nd place
3rd place
195th place
255th place
447th place
751st place
low place
1,853rd place
615th place
1,230th place
123rd place
6th place
low place
low place
low place
low place
low place
low place

akdae.de

businesswire.com

dguv.de

gestis.dguv.de

doi.org

europa.eu

ema.europa.eu

fachinfo.de

fda.gov

gkv-spitzenverband.de

multiplesklerose.ch

neurology.org

  • Richard Macdonnell, Guy Nagels, Per Solberg Sorensen, David Laplaud, Carlo Pozzilli, Ana Silva, Richard Nicholas, Mathias Niedhammer, Julia Gaebler, Sonalee Agarwal and James Potts: Change in Quality of Life Outcomes with Prolonged-Release Fampridine Treatment: Interim Analysis of the ENABLE Study. In: Neurology. Band 80, Supp. 7, 2013, S. P03.218–P03.218 (neurology.org).

nih.gov

ncbi.nlm.nih.gov

  • T. Pickett, R. Enns: Atypical presentation of 4-aminopyridine overdose. In: Ann Emer Med. 27, 1996, S. 382–385. PMID 8599505.
  • N. Johnson, M. Morgan: An unusual case of 4-aminopyridine toxicity. In: J Emer Med. 30, 2006, S. 175–177. PMID 16567254.
  • A. D. Goodman, T. R. Brown, L. B. Krupp u. a.: Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. In: The Lancet. 373, 2009, S. 732–738. PMID 19249634.
  • A. D. Goodman, T. R. Brown, K. R. Edwards u. a.: A phase 3 trial of extended release oral dalfampridine in multiple sclerosis. In: Ann Neurol. 68, 2010, S. 494–502. PMID 20976768.
  • Raymond Lamore III, Elsen Jacob, Susan C. Jacob, Olga Hilas: Dalfampridine (Ampyra). In: Pharmacy and Therapeutics. Band 35, Nr. 12, 2010, S. 665–669, PMC 3008376 (freier Volltext).

chem.nlm.nih.gov

pubchem.ncbi.nlm.nih.gov

orst.edu

extoxnet.orst.edu

sigmaaldrich.com

swissmedic.ch

web.archive.org

who.int

apps.who.int

  • Recommended International Nonproprietary Names for Pharmaceutical Substances. INN List 35. In: WHO Drug Information. Band 9, Nr. 3, 1995, S. 174 (who.int [PDF]).

zdb-katalog.de